Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Prelude Therapeutics Incorporated (PRLD)

Abeona Therapeutics Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Abeona Therapeutics Inc. and Prelude Therapeutics Incorporated are of similar size ($265.9M and $265.0M). Abeona Therapeutics Inc. has the higher net margin (−242.6% vs −269.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Abeona Therapeutics Inc. leads on 8 and Prelude Therapeutics Incorporated on 7.

Valuation

Metric ABEO PRLD Biotechnology median
P/E n/m n/m 8.50
P/S 9.68 14.30 9.71
P/B 1.96 2.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.60 7.54 9.21
Earnings yield (26.59%) (22.39%) (33.15%)
Free cash flow yield (32.48%) (10.39%) (25.50%)

Profitability

Metric ABEO PRLD Biotechnology median
Gross margin 66.03% 100.00% 65.16%
Operating margin (322.59%) (300.56%) 0.00%
Net margin (242.62%) (269.75%) 0.00%
Free cash flow margin (314.53%) (148.30%) 0.00%
Return on equity (43.13%) (57.73%) (56.36%)
Return on assets (29.54%) (39.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABEO PRLD Biotechnology median
Revenue growth (TTM) 427.47% — 6.02%
EPS growth (last fiscal year) 165.16% 23.21% 30.26%
Revenue growth, 5-year CAGR 14.19% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO PRLD Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 4.07 4.72
Net debt to EBITDA 2.00 1.00 0.96

Dividend

Metric ABEO PRLD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO PRLD Biotechnology median
Market cap 265.90m 264.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack